Detailed narrative
Section 232 Proclamation and U.S. Strategy
The recent Section 232 determination on polysilicon and its derivatives, effective December 4, 2026, is seen as a positive development for TOYO, supporting stronger module pricing. The proclamation establishes minimum import prices and an investment-linked onshoring program, allowing duty-free imports for qualified companies. TOYO intends to pursue an onshoring plan centered on its Humble, Texas HJT cell facility, leveraging its significant U.S. investment and use of U.S.-produced polysilicon (70% currently, targeting 100% by Q4 2026 for Ethiopian production).
HJT Cell Facility Expansion in Humble, Texas
TOYO plans to invest approximately $357 million in an advanced Heterojunction (HJT) solar cell facility in Humble, Texas. The initial phase is designed for approximately 1.5 gigawatts of annual production capacity. Pilot production is targeted for Q4 2027 or Q1 2028, creating approximately 400 direct jobs. This facility will bring next-generation cell manufacturing and R&D to the same U.S. campus as their module operations, which are on track to reach 2 gigawatts of annual capacity by September 2026.
CBP Reviews and Ethiopia Anticircumvention Inquiry
During Q2, CBP reviews led to detentions of some shipments from TOYO's Ethiopian facility. The company is cooperating fully, providing detailed records to trace materials from polysilicon source to U.S. entry. Separately, Commerce initiated an anticircumvention inquiry concerning Ethiopian cells using Chinese components. TOYO states it does not use Chinese-origin wafers in its Ethiopian cell manufacturing and sources 100% of polysilicon outside of China, with 70% from a U.S. producer.
Financial Performance Highlights
For H1 2026, revenue was $361.7 million, an 87.6% YoY increase. Gross margin expanded to 32.5% from 16.6%. Net income was $45.8 million, up significantly from $2.5 million in H1 2025. Q2 2026 revenue was $118.2 million, up 35% YoY, with net income of $17.4 million. Non-GAAP EBITDA for H1 2026 was $82.1 million, compared to $21.5 million in H1 2025, driven by revenue scale and gross margin improvement.
Capital and Liquidity
As of June 30, 2026, the company held $123.4 million in cash and restricted cash, an increase from $85.9 million at December 31, 2025. Working capital turned positive at $29.8 million, a significant improvement from a $123.9 million deficit. The company generated $51.4 million in cash from operations and incurred $27.8 million in capital expenditures during H1 2026. Net proceeds of $53.6 million were raised through direct and at-the-market offerings.